Ainos (OTCMKTS:AIMD) Stock Price Up 14.7% – Here’s Why

Ainos, Inc. (OTCMKTS:AIMD)’s share price shot up 14.7% on Wednesday . The stock traded as high as $0.52 and last traded at $0.51. 665,119 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 983,083 shares. The stock had previously closed at $0.44.

Ainos Price Performance

The company has a quick ratio of 1.45, a current ratio of 1.92 and a debt-to-equity ratio of 0.08. The company has a market cap of $4.06 million, a price-to-earnings ratio of -0.20 and a beta of 1.40. The company has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.73.

Ainos (OTCMKTS:AIMD) last released its earnings results on Monday, August 5th. The company reported ($0.49) earnings per share for the quarter. Ainos had a negative return on equity of 44.32% and a negative net margin of 515.80%.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.